Company · CIK 0001691082 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
LB PHARMACEUTICALS INC · LBRX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
No reported common-stock activity in this period.
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 30, 2026 PForm 4 → | Aug 3, 7:28 pm EDT | Deep Track Biotechnology Master Fund, Ltd. +210% Owner | 286,205 | $34.94 | $9,999,974 | 664,649 | — | |
| Jun 3, 2026 AForm 4 → | Jun 5, 6:04 pm EDT | Robert R RuffoloDirector | 10,000 | — | — | 10,000 | — | |
| Jun 3, 2026 AForm 4 → | Jun 5, 5:35 pm EDT | Ran NussbaumDirector | 10,000 | — | — | 10,000 | — | |
| Jun 3, 2026 AForm 4 → | Jun 5, 5:32 pm EDT | Rebecca LuseDirector | 10,000 | — | — | 10,000 | — | |
| Jun 3, 2026 AForm 4 → | Jun 5, 5:26 pm EDT | Robert A. LenzDirector | 12,500 | — | — | 12,500 | — | |
| Jun 3, 2026 AForm 4 → | Jun 5, 5:25 pm EDT | Rekha HemrajaniDirector | 10,000 | — | — | 10,000 | — | |
| Jun 3, 2026 AForm 4 → | Jun 5, 5:23 pm EDT | William P Kane Jr.Director | 10,000 | — | — | 10,000 | — | |
| Jun 3, 2026 AForm 4 → | Jun 5, 5:22 pm EDT | J. Scott GarlandDirector | 10,000 | — | — | 10,000 | — |